Scientific article
Open access

Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction

Published inScientific reports, vol. 6, 38300
Publication date2016

Accurately determining time-of-onset of cerebral infarction is important to clearly identify patients who could benefit from reperfusion therapies. We assessed the kinetics of peroxiredoxin 1 (PRDX1), a protein involved in oxidative stress during the acute phase of ischemia, and its ability to determine stroke onset in a population of patients with known onset of less than 24 hours and in a control group. Median PRDX1 levels were significantly higher in stroke patients compared to controls. PRDX1 levels were also higher from blood samples withdrawn before vs. after 3 hours following stroke onset, and before vs. after 6 hours. ROC analysis with area under the curve (AUC), sensitivity (Se) and specificity (Sp) determined from the Youden index was performed to assess the ability of PRDX1 levels to determine onset. Diagnostic performances of PRDX1 levels were defined by an AUC of 69%, Se of 53% and Sp of 86% for identifying cerebral infarction occurring <3 hours, and an AUC of 68%, Se of 49% and Sp of 88% for cerebral infarction occurring <6 hours. These first results suggest that PRDX1 levels could be the basis of a new method using biomarkers for determining cerebral infarction onset.

Citation (ISO format)
RICHARD, Sébastien et al. Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction. In: Scientific reports, 2016, vol. 6, p. 38300. doi: 10.1038/srep38300
Main files (1)
Article (Published version)
ISSN of the journal2045-2322

Technical informations

Creation12/13/2016 10:33:00 AM
First validation12/13/2016 10:33:00 AM
Update time03/15/2023 1:09:51 AM
Status update03/15/2023 1:09:51 AM
Last indexation05/02/2024 6:01:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack